Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBL-514 Factorial Study for Abdominal Subcutaneous Fat
NCT06005441Phase 2Completed
- Sponsor
- Caliway Biopharmaceuticals
- Start
- Nov 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CBL-514, sponsored by Caliway Biopharmaceuticals. Started Nov 2023; status: completed.
02
Drugs
CBL-514
Beyond the preview
Go deeper on NCT06005441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06005441.